cyc 202 has been researched along with gallic acid in 1 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (gallic acid) | Trials (gallic acid) | Recent Studies (post-2010) (gallic acid) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 4,793 | 42 | 2,579 |
| Protein | Taxonomy | cyc 202 (IC50) | gallic acid (IC50) |
|---|---|---|---|
| Urokinase-type plasminogen activator | Homo sapiens (human) | 6.6 | |
| Tissue-type plasminogen activator | Homo sapiens (human) | 6.6 | |
| Plasminogen activator inhibitor 1 | Homo sapiens (human) | 6.6 | |
| Urokinase-type plasminogen activator | Mus musculus (house mouse) | 6.6 | |
| 72 kDa type IV collagenase | Homo sapiens (human) | 4.03 | |
| Matrilysin | Homo sapiens (human) | 4.03 | |
| Dipeptidyl peptidase 4 | Homo sapiens (human) | 4.65 | |
| Alpha-synuclein | Homo sapiens (human) | 4.43 | |
| 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 | Homo sapiens (human) | 4.03 | |
| Polypeptide N-acetylgalactosaminyltransferase 2 | Homo sapiens (human) | 1.37 | |
| Alpha-(1,3)-fucosyltransferase 7 | Homo sapiens (human) | 4.03 | |
| CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 | Homo sapiens (human) | 4.03 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babu, KS; Bondon, A; Boustie, J; Ferron, S; Graton, J; Jacquemin, D; Le Lamer, AC; Le Pogam, P; Legouin, B; Obermayer, W; Rouaud, I; Siva, B | 1 |
1 other study(ies) available for cyc 202 and gallic acid
| Article | Year |
|---|---|
Minor Pyranonaphthoquinones from the Apothecia of the Lichen Ophioparma ventosa.
Topics: Antineoplastic Agents; Biphenyl Compounds; Circular Dichroism; Drug Screening Assays, Antitumor; Fruiting Bodies, Fungal; Humans; Inhibitory Concentration 50; Lichens; Molecular Structure; Naphthoquinones; Nuclear Magnetic Resonance, Biomolecular; Picrates; Pyrans | 2016 |